Market Tracker

07/30 3:13pm ET

Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

61.09
Real-Time Quote
 +0.06 / +0.10%
Today’s Change
55.04
Today|||52-Week Range
84.25
-13.16%
Year-to-Date

Today’s Trading

Previous close61.03
Today’s open61.71
Day’s range60.76 - 62.93
Volume842,147
Average volume (3 months)1,264,032
Market cap$8.9B
Dividend yield--
Data as of 2:58pm ET, 07/30/2014

Growth & Valuation

Earnings growth (last year)-34.74%
Earnings growth (this year)-34.75%
Earnings growth (next 5 years)+12.50%
Revenue growth (last year)+10.82%
P/E ratioNM
Price/Sales17.67
Price/Book6.53

Competitors

 Today’s
change
Today’s
% change
HSPHospira Inc+3.89+7.50%
PCYCPharmacyclics Inc-1.22-0.98%
SLXPSalix Pharmaceutical...+4.00+3.04%
JAZZJazz Pharmaceuticals...+1.17+0.84%
Data as of 3:13pm ET, 07/30/2014

Financials

Last reporting dateJuly 30, 2014
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$548.4M
Annual profit (last year)-$176.4M
Net profit margin-32.15%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Daniel K. Spiegelman
Corporate headquarters
San Rafael, California

Forecasts